GSA Capital Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
170,533
+147,448
| +639% | +$945K | 0.08% | 401 |
|
|
2025
Q1 | $82K | Buy |
23,085
+12,446
| +117% | +$44.2K | 0.01% | 1520 |
|
|
2024
Q4 | $40K | Buy |
+10,639
| New | +$40K | ﹤0.01% | 1541 |
|
|
2024
Q2 | – | Sell |
-79,652
| Closed | -$226K | – | 1596 |
|
|
2024
Q1 | $226K | Sell |
79,652
-52,525
| -40% | -$149K | 0.02% | 1352 |
|
|
2023
Q4 | $1.95M | Buy |
132,177
+89,742
| +211% | +$1.32M | 0.16% | 128 |
|
|
2023
Q3 | $777K | Buy |
42,435
+28,431
| +203% | +$521K | 0.07% | 535 |
|
|
2023
Q2 | $302K | Buy |
14,004
+5,895
| +73% | +$127K | 0.03% | 1046 |
|
|
2023
Q1 | $238K | Buy |
+8,109
| New | +$238K | 0.02% | 1160 |
|